|
PLATELET CALMODULIN LEVELS
IN ADOLESCENT IDIOPATHIC SCOLIOSIS (AIS): A PREDICTOR OF CURVE PROGRESSION
AND SEVERITY?
Thomas Lowe, MD1,
David Lawellin, PhD2,
Yinong Kong, MD1,
Michael O'Brien, MD1,
David Smith, MSc1,
Charles Price, MD3,
Marc Asher, MD4,
Thomas Haher, MD5,
Andrew Merola, MD5 ·
*(a Scoliosis Research Society)
1Wheat Ridge, CO,
2 Denver, CO,
3 Orlando, FL,
4 Kansas City, KS,
5 New York, NY, USA
INTRODUCTION:
Abnormalities of skeletal muscle and platelets have been identified in
patients with AIS. Calmodulin is a calcium binding receptor protein which
mediates muscle contractility (actin and myosin) in the platelet. Previous
studies have suggested a possible direct relationship between calmodulin
and curve progression based on a single calmodulin determination correlated
with serial radiographs.
PURPOSE:
To determine whether serial platelet calmodulin levels correlate with
curve progression and severity in patients with AIS over a period of time
during growth. MATERIALS AND
METHODS:
55 patents with AIS of varying degrees of severity and curve types (King
IIV) were followed longitudinally during the growth period with simultaneous
erect PA radiographs and blood draws for platelet calmodulin. There were
61 females and 4 males. Treatment consisted of observation in 28, brace
treatment in 17 and spinal fusion in 10 patents. Tanner scores as well
as Risser signs were recorded at each visit.
RESULTS:
In the 13 patents with > 10° progression there was a 100% positive correlation
with increasing calmodulin levels. In the 42 patents with nonprogressive
curves, 31 (74%) had stable calmodulin levels (P< 0.0001).
|
|
Patients Calmodulin
|
Patients Calmodulin
|
Total #
|
|
|
Levels Increased
|
Level Stable
|
Patients
|
| |
|
|
|
|
Progression <10
|
11 (26%)
|
31 (74%)
|
42
|
|
Progression >=10
|
13 (100%)
|
0 (0%)
|
13
|
|
|
24
|
31
|
55
|
Calmodulin levels were generally higher
in patents with curves > 30° compared to those with curve < 30°. Patents
with double primary curves had higher calmodulin levels than patents with
thoracic, thoracolumbar or lumbar curves. Pvalues were 0.018, 0.025 and
0.052 respectively. Calmodulin levels decreased in patents undergoing
either brace treatment following surgery or at skeletal maturity.
CONCLUSIONS:
It appears that increasing platelet calmodulin levels correlate closely
with curve progression and severity and that both treatment (brace or
surgery) and skeletal maturity correlate with decreasing calmodulin levels.
Further investigation is necessary to determine whether in conjunction
with standard radiographs, calmodulin may serve as a biochemical marker
to assist in following patients with potential curve progression and to
identify curves which have stabilized.
·* If noted, the author indicates something of value received. The codes
are identified as: a research or institutional support, bmiscellaneous
funding, croyalties, dstock options, econsultant.
|
|